FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

✍ Scribed by Amiri-Kordestani, L.; Blumenthal, G. M.; Xu, Q. C.; Zhang, L.; Tang, S. W.; Ha, L.; Weinberg, W. C.; Chi, B.; Candau-Chacon, R.; Hughes, P.; Russell, A. M.; Miksinski, S. P.; Chen, X. H.; McGuinn, W. D.; Palmby, T.; Schrieber, S. J.; Liu, Q.; Wang, J.; Song, P.; Mehrotra, N.; Skarupa, L.; Clouse, K.; Al-Hakim, A.; Sridhara, R.; Ibrahim, A.; Justice, R.; Pazdur, R.; Cortazar, P.

• Book ID: 125530039
• Publisher: American Association for Cancer Research
• Year: 2014
• Tongue: English
• Weight: 262 KB
• Volume: 20
• Category: Article
• ISSN: 1078-0432
• DOI: 10.1158/1078-0432.CCR-14-0012